BEAT News and Press, Heartbeam Inc. From 01/24/23

Senior Medical Technology Executive to Enhance Company’s Strategic and Operations Capabilities HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, an...

HeartBeam (NASDAQ: BEAT) , a cardiac technology company with a track record for innovation and cutting-edge technology, recently announced that it was granted a patent for its 12-lead electrocardiogram (“ECG”) smartwatch-based monitor designed to identify heart attacks and complex c...

HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, was featured in a new C-level interview with Traders News Source, a leading independent equity research and corporate access firm fo...

NEW YORK, NY / ACCESSWIRE / January 12, 2023 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Heartbeam. Toni had the pleasure of recently conducting the Int...

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has been issued a patent by the European Patent Office. The company received notification that th...

HeartBeam ( NASDAQ: BEAT ) said it was granted European patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG). This patent offers protection for HeartBeam’s technology in multiple countries in Europe and has been validated ...

Patented Technology Provides Protection for HeartBeam AIMIGo ™ Credit Card-sized Device in European Market HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywher...

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has issued a letter to shareholders. The letter, signed by HeartBeam CEO and founder Branislav Va...

MedTech company HeartBeam, Inc ( NASDAQ: BEAT ) announced Thursday that it will start filing for its version 1 and version 2 HeartBeam AIMIGo telehealth solutions in early 2023. The company, which offers ECG-based telemedicine technology for heart attack detection, filed a so-called 5...

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, today issued a letter to shareholders from its Chief Executive Officer and Founder, Branislav Vajdic, PhD....